High-Resolution Magic-Angle-Spinning NMR in Revealing Hepatoblastoma Hallmarks.
cancer NMR-metabolomics
hepatoblastoma
liver metabolome
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
01 Dec 2022
01 Dec 2022
Historique:
received:
02
11
2022
revised:
21
11
2022
accepted:
23
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Cancer is one of the leading causes of death in children and adolescents worldwide; among the types of liver cancer, hepatoblastoma (HBL) is the most common in childhood. Although it affects only two to three individuals in a million, it is mostly asymptomatic at diagnosis, so by the time it is detected it has already advanced. There are specific recommendations regarding HBL treatment, and ongoing studies to stratify the risks of HBL, understand the pathology, and predict prognostics and survival rates. Although magnetic resonance imaging spectroscopy is frequently used in diagnostics of HBL, high-resolution magic-angle-spinning (HR-MAS) NMR spectroscopy of HBL tissues is scarce. Using this technique, we studied the alterations among tissue metabolites of ex vivo samples from (a) HBL and non-cancer liver tissues (NCL), (b) HBL and adjacent non-tumor samples, and (c) two regions of the same HBL samples, one more centralized and the other at the edge of the tumor. It was possible to identify metabolites in HBL, then metabolites from the HBL center and the border samples, and link them to altered metabolisms in tumor tissues, highlighting their potential as biochemical markers. Metabolites closely related to liver metabolisms such as some phospholipids, triacylglycerides, fatty acids, glucose, and amino acids showed differences between the tissues.
Identifiants
pubmed: 36551847
pii: biomedicines10123091
doi: 10.3390/biomedicines10123091
pmc: PMC9775661
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : São Paulo Research Foundation
ID : #2018/24069-3, #2018/06510-4
Organisme : Organisation for the Prohibition of Chemical Weapons
ID : L/ICA/ICB/221146/19
Références
Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9
pubmed: 26979502
Methods Mol Biol. 2017;1546:275-282
pubmed: 27896777
EMBO Mol Med. 2017 Nov;9(11):1589-1604
pubmed: 28923827
Tumour Biol. 2020 Dec;42(12):1010428320977124
pubmed: 33256542
Front Oncol. 2021 Jul 21;11:690641
pubmed: 34367972
Dis Model Mech. 2013 Nov;6(6):1353-63
pubmed: 24203995
Hum Pathol. 2009 Jun;40(6):783-94
pubmed: 19200579
Transl Res. 2017 Nov;189:13-29
pubmed: 28668521
Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10
pubmed: 18953024
Int J Biochem Cell Biol. 2020 Aug;125:105773
pubmed: 32450267
Front Oncol. 2020 Oct 16;10:506959
pubmed: 33178572
Metabolites. 2019 Jun 27;9(7):
pubmed: 31252628
Mol Cancer. 2017 Apr 11;16(1):76
pubmed: 28399876
Anal Chem. 2014 Jun 17;86(12):5946-54
pubmed: 24856256
Redox Biol. 2018 Apr;14:47-58
pubmed: 28866248
Oncogene. 2002 Nov 28;21(54):8293-301
pubmed: 12447692
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Nat Rev Drug Discov. 2016 Jul;15(7):473-84
pubmed: 26965202
Adv Drug Deliv Rev. 2020;159:245-293
pubmed: 32711004
Ital J Pediatr. 2020 Aug 5;46(1):113
pubmed: 32758256
Toxins (Basel). 2018 Oct 28;10(11):
pubmed: 30373285
Nucleic Acids Res. 2008 Jan;36(Database issue):D402-8
pubmed: 17984079
Biomolecules. 2019 Dec 08;9(12):
pubmed: 31817982
Cancer Cell. 2008 Dec 9;14(6):471-84
pubmed: 19061838
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Res. 1999 Jan 15;59(2):269-73
pubmed: 9927029
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Lancet Oncol. 2017 Jan;18(1):122-131
pubmed: 27884679
Semin Pediatr Surg. 2016 Oct;25(5):265-275
pubmed: 27955729
J Cancer Res Clin Oncol. 2021 Nov;147(11):3169-3181
pubmed: 34235580
J Hepatol. 2014 Dec;61(6):1312-20
pubmed: 25135868
Hepatology. 2017 Jan;65(1):104-121
pubmed: 27775819
Clin Cancer Res. 2017 Jul 1;23(13):e115-e122
pubmed: 28674120